Trial intelligence / Profile preview

Bioequivalence of Eszopiclone vs Lunesta in Healthy Adults

NCT02322645Phase 1Completed

Sponsor
Dr. Reddy's Laboratories
Start
Aug 2008
Primary completion
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of eszopiclone in Insomnia (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area under curve at 48 hours. Started Aug 2008; status: completed.

02

Drugs

eszopiclone
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT02322645.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02322645.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call